[144] Snowflake Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 for Snowflake Inc. (SNOW) shows proposed and recent insider sales by Michael P. Scarpelli. The notice reports a planned sale of 323,078 common shares through Fidelity Brokerage on 09/26/2025, with an aggregate market value of $72,269,439.69. The filing states the securities were acquired via an option granted 08/27/2019 and paid for in cash on 09/26/2025. The filer also disclosed three recent sales during the prior three days: 318,533 shares on 09/23/2025 for $72,581,088.65, 85,099 shares on 09/24/2025 for $19,172,557.91, and 176,922 shares on 09/25/2025 for $39,388,781.78. The notice includes the standard certification that the seller is not aware of any undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: A named insider executed sizeable block sales across consecutive days and intends an additional large sale, which may reflect personal liquidity rather than company fundamentals.
The filing discloses that Michael P. Scarpelli sold a total of 580,554 shares across 09/23–09/25/2025 and intends to sell another 323,078 shares on 09/26/2025. The planned sale's reported aggregate market value is $72.27 million, while the three prior-day sales generated roughly $131.14 million in gross proceeds combined. Relative to the issuer's reported outstanding shares of 338,800,000, each transaction represents a small fraction of total equity, but the concentrated timing and large dollar amounts are notable for trading flow and short-term supply pressure. The filing indicates acquisition via an option granted in 2019 and cash payment on the stated sale date, which is consistent with routine option exercises followed by disposition.
TL;DR: Repeated insider dispositions over consecutive days warrant attention to insider intent and disclosure controls, though the filing affirms no undisclosed material information.
The Form 144 includes the required attestation that the seller does not possess undisclosed material adverse information. Sales were processed through Fidelity Brokerage and list the historical grant date (08/27/2019) for the option underlying the shares. From a governance perspective, clustering of sales by a named officer or insider can raise investor questions about timing, trading plans, or liquidity needs. The filing does not state a 10b5-1 plan adoption date or other mitigating details, so readers must rely solely on the attestation provided.